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Abstract: Within the genus Mycobacterium (M.) more than 170 different types of 
mycobacteria have been identified. In relation to humans, they are divided into three 
groups. M. tuberculosis complex, which includes ten species that cause tuberculosis 
in mammals. The type of M. tuberculosis within M. tuberculosis complex remains 
the major cause of tuberculosis in humans in the world. Except for a long time known 
species (M. bovis, M. africanum, M. microti, M. canetti, M. caprae), new members 
of the group have recently been discovered. M. pinnipedii in seals, M. munghi in 
mongoose, M. orygis in arabian oryx and M. suricattae in the meerkat. The same 
causes have been proven in people living nearby. M. leprae is the cause of the 
leprosy in humans. The disease has been proven in nine banded armadillos (Dasypus 
novemcinctus) and represents the natural reservoir of M. leprae. The largest number 
of mycobacteria (more than 160 species) belongs to nontuberculous mycobacteria. 
They are found in the environment, they are very resistant and adapted to growth 
and development, and to humans and animals are often exposed to them. Some 
are important potentially pathogenic species and they sometimes cause severe 
pathological processes in humans and animals.
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Mycobacterium is the single genus 
within the family of Mycobacteriaceae. 
The number of species within the genus 
Mycobacterium has been changing 
over the last few years, and more 
than 170 different species have been 
identified. Each year, three to ten new 
types of mycobacterium are discovered 
(Tortoli, 2014). In the period from 
2003 to 2012, more than 60 different 
types of mycobacteria were detected 
(Biet and Boschiroli, 2014; Žolnir-
Dovč and Pate, 2015). In relation to 
humans, the genus Mycobacterium can 
be divided into three main groups: 1. 
Mycobacterium tuberculosis complex, 
this group includes species that 
cause tuberculosis in mammals (M. 
tuberculosis, M. africanum, M. canettii, 
M. bovis, M. caprae , M. microti, M. 
pinnipedii, M. mungi, M. orygis, and 
in 2013 the species M. suricattae was 
described); 2. Mycobacterium leprae 
- this group belongs to the M. leprae 
species that causes leprosy in humans; 
3. Nontuberculous mycobacteria (NTM) 
- includes all other species (> of 160 
species), which, unlike the previous 
groups, doesn’t include obligate 
pathogens. Most of these mycobacteria 
are saprophytes, symbionts and 
commensals, and are found in our 
environment. Some of them may be 
potentially (opportunistic) pathogens 
in animals and humans, and man and 
animals may be infected by direct contact 
or aerosol (Van Ingen, 2013). It is known 
that pathogenic mycobacterium have 
their preferred hosts, but occasionally 
they can cause infection in other species. 
Diseases caused by mycobacterium in 
domestic animals are usually chronic 
and progressive. Members of the 
M. tuberculosis complex cause very 
different pathological changes in 
different types of mammals (Table 1). 
(Quinn et al., 2011).
INTRODUCTION
Table 1. Review of mycobacterium pathogenic to animals and humans (Quinn et 
al., 2011).
Mycobacterium
Species Main host
Occasionally 
infected species Disease
M. tuberculosis 
complex
M. tuberculosis Man, primates (captivated)
Dogs, cattle, 
psittacines, 
canaries
Tuberculosis (the 
whole world)
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M. bovis Cattle
deer, badgers, 
opossums,cats, 
man, other 
mammals
Tuberculosis
M. africanum Man Sometimes other types of mammals
Tuberculosis 
(mainly Western 
Africa)
M. canettii Man
Tuberculosis 
(mainly Eastern 
Africa)
M. microti Voles Sometimes other types of mammals Tuberculosis
M. caprae Goat Cattle Tuberculosis
M. pinnipedii Seal, sea lions
Sometimes other 
types of mammals 
including humans
Tuberculosis
M. avium 
kompleks
Many bird 
species except 
psittacines
Pigs, cattle Tuberculosis
M. marinum Fish
Humnas, aquatic 
mammals, 
amphibians
Tuberculosis
M. ulcerans Man Koala, opossum Buruli ulcer
M. leprae Man Armadillos, chimpanzees Leprosy
M. lepraemurium Rats, mice Cats Rat leprosy, Feline leprosy
M. avium subsp.
 paratuberculosis
Cattle, sheep, 
goats, deer Other ruminants Paratuberculosis
Unspecified 
rapidly growing 
mycobacteria
Cattle
It is classified as 
skin tuberculosis 
(causes bovine 
sensitization during 
tuberculinization)
M. senegalense
M. farcinogenes Cattle
Chronic 
lymphadenitis
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Species from the M. tuberculosis 
complex remain the main causes of 
tuberculosis in the world, especially 
in developing countries, despite 
considerable progress in diagnosis 
and treatment (Sinha et al., 2016). M. 
tuberculosis is the cause of tuberculosis 
in humans, and occasionally it can cause 
tuberculosis in animals. It appears in the 
whole world. It can be divided into two 
major types: the classical type originally 
isolated by Koch and the South Indian 
or Asian type. The South Indian or Asian 
type is isolated in Madras in southern 
India, and it differs from a classical in 
regard to low virulence for guinea pigs, it 
is virulent for humans and causes similar 
illness as the classical type. About 60% 
of the tuberculosis isolated in Madras 
region was of this type, and it was 
discovered in Asian communities and in 
other parts of the world. The incidence 
of infection with M. tuberculosis in 
animals decreases in proportion to 
the rarer occurrence of tuberculosis 
in humans. The following animals 
are susceptible to M. Tuberculosis: 
donkeys, horses, cattle, carnivores, 
pigs, elephants, aquatic mammals, deer, 
antelopes and psittacines (Grange and 
Redmond, 1978; Smith, 2003) M. bovis 
is primarily pathogenic to cattle but 
goats, camels, horses, pigs, dogs and cats 
are also susceptible to this bacterium. M. 
bovis causes a small number of cases of 
tuberculosis in humans. The causative 
agent in many countries has economic 
significance in wild and domestic 
animals around the world, especially in 
underdeveloped countries where there is 
little data on the incidence of  M. Bovis 
infection in humans (LoBue et al., 2010).
M. africanum, a common cause of 
tuberculosis in western Africa, was 
first recognized in Senegal in 1968 as 
a subspecies of the M. tuberculosis 
complex. It is divided into two variants: 
the African I variant , which is isolated 
from the man in East Africa and the 
African II variant isolated in West Africa 
and similar to M. bovis. It is similar to M. 
bovis because it’s microaerophilic and 
susceptible to TCH, but it is also similar 
to M. tuberculosis due to its susceptibility 
to pyrazinamide. Isolates from Africa 
(Dakar, Mauritania) are more similar 
to M. bovis, while those from eastern 
Africa (Rwanda and Burudni) are similar 
to M. tuberculosis. Biochemical tests of 
M. africanum give very variable results, 
so molecular genotyping is used in the 
identification. A revised classification 
was proposed including West African 
1 and West African 2 as distinct sub-
species within the M. tuberculosis 
complex (De Jong et al., 2009).
M. microti was first isolated from 
tuberculous processes in voles. It is 
slightly different from M. tuberculosis 
and some researchers consider it to 
be a subspecies of M. tuberculosis. 
Tuberculosis in wild rodents was first 
discovered in 1927 as part of a study of 
cyclic density changes in vole populations. 
Common voles, wood mice and various 
MYCOBACTERIUM TUBERCULOSIS COMPLEX
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other types of mice are particularly 
susceptible to infection with M. microti. 
However, other small mammals such as 
guinea pigs, rabbits, mice and rats are 
resistant to M. microti infection, even at 
high doses of infection. Sporadic cases 
are described in larger mammals (cattle, 
llama, cat) and in humans (Emmanuel 
et al., 2007). M. canetti was first 
described by the French microbiologist 
Georges Canetti in 1969. In 1997, it was 
described in more details on the basis 
of isolates isolated from a 2-year-old 
Somali child with lymphadenitis. Later, 
abdominal lymphatic TB was diagnosed 
in a 56-year-old Swiss man with HIV 
infection who lived in Kenya. Miltgen 
et al. (2002) identified an unusual type 
of mycobacteria in two patients with 
pulmonary tuberculosis. M. canettii 
species was identified from the samples. 
Tuberculosis caused by M. canetti 
appears as an important disease in 
southern Africa. As traveling to this area 
becomes more common, and techniques 
for identification of mycobacteria are 
improving, it is expected that the number 
of diagnosed cases caused by this species 
will be higher. Possible natural reservoirs 
and mode of transmission are still not 
fully known (Van Soolingen et al., 1997; 
Pfyffer et al., 1998). 
M. caprae is a new member of the 
M. tuberculosis complex, isolated in 
1999 from the lymph nodes and lungs of 
goats. By its phenotypic and genotypic 
traits it differs from other members of 
this complex. Several years later (2002 
and 2003) it was confirmed that this 
was a new species called Mycobacterium 
caprae. M. Caprae is a common cause of 
bovine tuberculosis in many countries 
of Europe, identified in deer and wild 
boars. In 2006, it was proved in cattle, 
pigs and people in Croatia (Aranaz et 
al., 2003; Cvetni et al., 2007). In 2006, 
it was detected in cattle, pigs and people 
in Croatia (Aranaz et al., 2003; Cvetni et 
al., 2007).
M. pinnipedii is a species isolated from 
seals in Australia, Argentina, Uruguay, 
Great Britain and New Zealand. A 
comparison of isolates from seals in 
Australia,Argentina, Uruguay, Great 
Britain and New Zealand was undertaken 
to determine their relationships to each 
other and their taxonomic position 
within the complex. Isolates from 
six species of seals were compared to 
representative and standard strains of 
the M. tuberculosis complex. Based on 
host preference, phenotypic and genetic 
tests, isolates differed from other species 
within the M. tuberculosis complex. 
Seals appear to be the natural host for 
this organism causing granulomatous 
lesions in the peripheral lymph nodes, 
lungs, pleura, spleen and peritoneum. 
Cases of disseminated disease have been 
found. The causative agent is thought to 
be the most commonly transmitted by 
aerosol (Cousins  et al., 2003).
Several epizootics of tuberculosis 
in banded mongoose (Mungos mungo) 
caused by M. mungi, have been described.
in the Chobe District in Botswana. Banded 
mongooses are social animals living in 
close association with humans and they 
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scavenge human waste. Tuberculosis 
disease in banded mongooses was 
initially identified in 2000 and infection 
spread through cities and the national 
park. The causative agent was identified 
by its characteristics similar to those of 
the M. tuberculosis complex (Alexander 
et al., 2002). From 2000 to 2010 there 
were seven epidemics with a higher 
number of banded mongooses, and the 
disease was identified in broad areas, 
including protected areas and urban 
centers. Tuberculosis was detected 
only in mongooses and humans. 
The estimation and distribution of 
tuberculosis in humans has not been 
performed. Isolation of the new agent 
presents a new threat to human health 
(Alexander et al., 2010).
M. orygis is a causative agent of 
tuberculosis in animals and humans 
from Africa and South Asia. It is first 
isolated from the Arabic oryx antelope 
(Oryx leucoryx). M. orygis was first 
characterized based on examination 
of 22 isolates ,eleven of these isolates 
were from animals (a and 11 were from 
humans from South Asia. It was proven 
to cause tuberculosis in animals and 
people from Africa and South Asia. 
Mycobacteria were isolated from samples 
originating from gazelles, deer, antelopes 
and water buffaloes. Bacterial isolates 
from antilopes are phylogenetically 
different from other members of the 
M. tuberculosis complex, and it was 
proposed that M.orygis was attributed 
a subspecies status (Van Ingen et al., 
2012).
M. suricattae is a microorganism 
that causes tuberculosis in meerkats 
(Suricata suricatta). Genetic analysis 
has shown that it is a new member 
of the Mycobacterium tuberculosis 
complex and is very similar to M. mungi. 
A study of meerkats in the Kalahari 
Desert shows that the disease is caused 
by a unique strain belonging to the M. 
tuberculosis complex. The new species 
is called M. suricattae (Parsons et al., 
2013). Tuberculosis was first diagnosed 
in free-living meerkats in South Africa’s 
Kalahari Desert with detailed description 
of epidemiology and pathology of the 
disease (Drewe et al., 2009; Drewe, 2010). 
Microbacteria previously isolated from 
meerkats were usually identified as M. 
tuberculosis (Alexander et al., 2002), M. 
bovis (Drewe et al., 2009) or as a member 
of the M. tuberculosis complex (Drewe, 
2011). The authors express concern 
about the appearance of tuberculosis in 
meerkats, and they believe that this is 
the result of anthropogenic exposure of 
these animals. Such infected populations 
may pose a risk for infection of other 
wild and domestic animals and humans 
(Drewe et al., 2009).
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MYCOBACTERIUM LEPRAE
M. leprae takes a special place in 
the division of mycobacteria because in 
vitro cultivation is not generally possible 
in spite of many efforts (Pattyn, 1994). 
This does not mean that in certain 
environmental conditions it can not be 
reproduced. One of the properties is 
that M. leprae is pathogenic to humans. 
In the US, Louisiana and Texas, leprosy 
has been detected in naturally infected 
armadillos (Dasypus novemcinctus). The 
disease has also been identified in one 
species of monkey (Cercocebus atys) and 
in chimpanzees (Walker and Lochwood, 
2007).
NONTUBERCULOUS MYCOBACTERIA 
Nontuberculous mycobacteria 
(NTM) are opportunistic pathogens of 
humans and animals. They are found in a 
wide variety of habitats to which humans 
and animals are exposed, including 
drinking water distribution systems and 
household water and plumbing, soil and 
dust. Human activities have had direct 
impacts on their ecology and thereby 
their epidemiology. In the middle of 
the 20th century mycobacteria that 
do not cause tuberculosis, are divided 
in four groups according to the rate of 
growth, the morphology of colonies and 
the production of pigments in light: 
slow-growing mycobacterium (non-
chromogens, photochromogens and 
scotochromogens) and rapid growing 
mycobacterium. Different terms such as 
“atypical mycobacteria”, mycobacteria 
from the environment, opportunistic 
mycobacteria or “other mycobacteria 
except M. tuberculosis” were used 
for them. Buhler and Pollack (1953) 
discovered lung disease in humans caused 
by M. kansasii, which was incredibly 
similar to tuberculosis. Since then, the 
attention to the pathogenic potency of 
nontuberculous mycobacteria has been 
intensified. The occurrence of human 
immunodeficiency (HIV) and the finding 
of a large number of different types of 
NTM even more increases the interest in 
these microorganisms. The development 
of new laboratory techniques, 
particularly in molecular biology, 
significantly influenced the detection, 
identification and evidence of new NTM 
species, which culminated in the later 
years of the 20th century. According to 
clinical relevance, they were divided into 
conditional pathogens, opportunistic 
mycobacteria and pure saprophytes 
(Davidson, 1989; Jankovic-Makek, 
2014). NTM are oligotrophic, able to grow 
at low organic matter concentrations 
and over a wide range of temperatures 
and even at low oxygen concentrations. 
They are resistant to disinfection, heavy 
metals and antibiotics, and compared 
to other types of mycobacteria they are 
highly resistant. NTM have been shown 
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NONTUBERCULOUS MYCOBACTERIA AND THE ENVIRONMENT
to be normal residents of drinking water 
distribution systems. They are resistant 
to various antimicrobial agents used for 
disinfection of drinking water and can 
spread to water distribution systems 
(Falkinham, 2010).
For almost three decades, it is known 
that non-tuberculous mycobacteria do 
not spread person-to-person and it is 
widely accepted that their source is the 
environment. The largest number of 
mycobacteria belonging to the genus 
Mycobacterium are nontuberculous 
mycobacteria. These are important, 
indispensable opportunistic pathogenic 
microorganisms and sometimes cause 
severe pathological processes in humans, 
poultry, birds and fish. Nontuberculous 
mycobacteria are saprophytes, 
symbionts and commensals,  and are 
isolated from the environment, most 
commonly from water and soil, domestic 
and wild animals, milk and dairy 
products, as well as from less well-known 
media such as biofilm, invertebrates and 
protozoa. Two of the most important 
factors are the cell wall of mycobacteria 
and their great adaptability (Biet et al., 
2005; Falkinham, 2009; Faria et al., 
2013). In Western countries it has been 
proven that as the number of infections 
with M. tuberculosis species decreases, 
the incidence of infections caused 
by nontuberculous mycobacteria is 
increasing (Hoefsloot et al., 2013). In the 
last few years, it has been proven that the 
amoeba is a large and important reservoir 
of nontuberculous mycobacteria. In 
the aquatic system of the hospital, the 
growth of Mycobacterium avium in 
Acanthamoeba lenticulata was proven. 
(Ovrutsky et al., 2013) An important 
feature of the mycobacterial cell is the 
presence of a hydrophobic, lipid-rich 
lipid membrane. Hydrophobicity is one 
of the most important features because 
it favors aerosolization, bacterial 
adhesion to surfaces, biofilm formation 
and resistance to disinfection and 
antibiotics. The NTM are oligotrophs, 
able to grow at low carbon levels , making 
them effective competitors in low 
nutrient, and disinfected environments 
such as water. Biofilm formation 
and oligotrophia led to survival and 
growth in drinking water systems and 
distributions (Falkinham, 2009). There 
are very interesting differences in the 
geographical distribution of certain 
types of nontuberculous mycobacteria, 
which for now can not be fully 
explained. The species from the M. 
avium complex prevail in most western 
countries and countries of the European 
Union, followed by  M. gordonae and M. 
xenopi, the other members of M. avium 
complex (M. Avium-intracellulare) and 
M. fortuitum are the following most 
frequently isolated nontuberculous 
mycobacteria (Van der der Werf et 
al., 2014). The species of M. avium 
complex is often isolated in the United 
States, followed by M. kansasii and M. 
abscessus. The study carried out in the 
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Middle East is significantly different, 
where the main isolated species were 
M. abscessus, M. fortuitum and M. 
intracellulare, followed by M. kansasii, 
M. gordonae and M. avium (Faria et 
al., 2015). In India M. fortuitum was 
most commonly isolated. In other Asian 
countries between the west (Singapore) 
and the east (Japan), species from the 
M. avium complex cause most of the 
infections (Simons et al., 2011).
MYCOBACTERIOSIS IN HUMANS
Nontuberculous mycobacteria  can 
cause mycobacteriosis in  humans. 
The disease mostly affect people with 
impaired immune system, the elderly, 
people with already existing lung 
diseases and occasionally in people with 
normal immune function. So far about 
25 types of NTM is often associated 
with mycobacteria in humans, other 
species (of which more than 160) are 
rarely associated with diseases, and 
most of them are microorganisms from 
the environment, so far not described as 
causing disease in humans (Van Ingen 
et al., 2013). Mycobacteriosis in humans 
can be roughly divided into four clinical 
forms (Griffith et al., 2007). Pulmonary 
mycobacteriosis is the most common 
clinical form of mycobacteriosis, 
and the symptoms are similar to 
pulmonary tuberculosis and can hardly 
be distinguished without laboratory 
diagnostics. They mainly occur in patients 
with pulmonary disease (eg cystic 
fibrosis, chronic bronchitis or chronic 
obstructive pulmonary disease - COPD). 
Pulmonary mycobacteriosis is usually 
manifested as slow progressive and very 
difficult to cure. The most common 
causes are M. avium and M. abscessus. 
Other forms of the disease are rare, and 
most commonly occur as lymphadenitis 
in children, especially those who are 
vaccinated with M. bovis BCG vaccine. 
The most common causitive agents are 
M. marinum, M. fortuitum, M. chelonae 
and M. abscessus. The disseminated 
form of mycobacteriosis is most common 
in people with a weakened immune 
system, such as patients with acquired 
immune deficiency syndrome (AIDS). 
This type of disease is most commonly 
caused by mycobacteria from the M. 
avium complex, M. simiae. There is also 
kin and soft tissue infection manifested 
by the formation of subcutaneous 
nodes, abscesses, ulcers, and are caused 
by M. abscessus, M. chelonae. Often 
granulomatous inflammation on the 
hands and feet can also be caused by the 
M. marinum species or rapidly growing 
mycobacteria such as M. fortuitum 
(Griffith et al., 2007; Van Ingen et al., 
2011; Žmak et al., 2013).
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NONTUBERCULOUS MYCOBACTERIA -CAUSATIVE AGENTS OF 
ANIMAL INFECTIONS
Many nontuberculous mycobacteria 
are opportunistic pathogens in animals 
and can cause lymphadenitis, lung, 
skin, soft tissue, tendon, joint and 
bone infections (Falkinham, 1999). 
It is well known that mycobacteria 
cause fish morbidity and mortality. 
Mycobacteriosis can occur in saltwater 
and freshwater fish that live in nature 
or are grown for human consumption 
or as decorative aquarium fish. For 
certain species of fish are M. marinum, 
M. fortuitum and M. chelonae are 
among the most common microbacterial 
agents.These mycobacteria may cause 
long-lasting illness that is difficult to 
treat in humans, especially those with 
low immune system (Gauthier and 
Rhodes, 2009). M. marinum is a well-
known and important mycobacteria that 
causes skin and soft tissue infections, 
and infected fish and contaminated 
water are the sources of infection. This 
type of mycobacteria is considered 
the most common nontuberculous 
mycobacterium that causes outbreaks of 
lung infections in humans (Aubry et al., 
2017).
More mycobacterial species can cause 
tuberculosis in birds, which is important 
in poultry production and breeding birds 
as pets. The most common cause of bird 
tuberculosis is M. avium, followed by M. 
genavense, and other less common types 
of mycobacteria, e.g. M. intracellulare, 
M. scrofulaceum and M. fortuitum 
(Dhama et al., 2011). Sensitivity to 
mycobacteria that causes tuberculosis 
in bird varies from species to species. 
The most sensitive is domestic poultry, 
sparrows, pheasants and partridges, 
and the most resistant is the domestic 
pigeon. Infected birds and contaminated 
water and soil are the most important 
source of infection, and these types of 
mycobacteria can survive for months 
in the environment. The disease is 
more common in crowded areas with 
poor hygiene (Tell et al., 2001). Similar 
differences in sensitivity to NTM were 
also observed among other animal 
species. Thus, pigs are particularly 
sensitive to infection caused by M. 
avium which can cause much damage to 
the economy (Cvetnić et al., 2006). Wild 
birds, pigs and some mammals today are 
the main reservoir of avian tuberculosis 
in nature. In the past few years in the 
poultry industry in the developed world 
this disease is declining, as a result 
of many changes in production and 
positive measures in the past. Lesser-
known species of NTM have so far been 
isolated in domestic and wild animals, 
but their role in these hosts, especially 
in the absence of clinical signs and 
pathomorphological changes, has not 
yet been clarified (Dhama et al., 2011).
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